Avanos Medical, Inc. · NYSE:AVNS

T. Rowe Price Investment Management, Inc. reported a 11.50% stake in Avanos Medical, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 7, 2026

T. Rowe Price Investment Management, Inc. reported a 11.50% stake in Avanos Medical, Inc., 5,330,776 shares, as a passive investor on Mar 31, 2026. Filed May 7, 2026 (Schedule 13G/A).

Stake
11.50%
Shares
5,330,776
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.11.50%5,330,776

Source

View original at SEC

Related